Skip to main content
. 2016 Jul 12;10(8):1305–1316. doi: 10.1016/j.molonc.2016.07.001

Figure 3.

Figure 3

Discrimination of PDAC stages vs. controls. (A) AUC‐values from SVM analysis with leave‐one‐out cross validation using unfiltered data (all antibodies), comparing NC to patients grouped according to their PDAC stage. (B) Antibodies with Wilcoxon p < 0.05 in one or more PDAC stages vs NC. Red = up‐regulated, blue = down‐regulated in PDAC vs NC, white = no significant difference.